| 尿激酶联合阿司匹林治疗慢性肺心病心力衰竭疗效观察 |
| |
| 引用本文： | 罗畅然. 尿激酶联合阿司匹林治疗慢性肺心病心力衰竭疗效观察[J]. 中国医药导报, 2010, 7(23) |
| |
| 作者姓名： | 罗畅然 |
| |
| 作者单位： | 广东省东莞市虎门医院,广东东莞,523902 |
| |
| 摘 要： | 目的:探讨尿激酶联合阿司匹林治疗慢性肺心病心力衰竭的临床疗效及安全性。方法:将80例慢性肺心病心力衰竭患者随机分为尿激酶联合阿司匹林组(观察组,40例)和阿司匹林组(对照组,40例),两组均常规使用倍他乐克、利尿剂、洋地黄类药,观察2周。结果:观察组有效率为85%,对照组有效率为65%,两组有效率比较,差异有统计学意义。结论:尿激酶联合阿司匹林治疗慢性肺心病心力衰竭是安全有效的。
|
| 关 键 词： | 慢性肺心病 心力衰竭 尿激酶 阿司匹林 |
Clinical observation of Urokinase and Aspirin in the treatment of chronicpulmonary heart disease with heart failure |
| |
| LUO Changran. Clinical observation of Urokinase and Aspirin in the treatment of chronicpulmonary heart disease with heart failure[J]. China Medical Herald, 2010, 7(23) |
| |
| Authors: | LUO Changran |
| |
| Affiliation: | LUO Changran (Humen Hospital of Dongguan City; Guangdong Province; Dongguan 523902; China); |
| |
| Abstract: | Objective:To investigate the clinical efficacy and safety of Urokinase and Aspirin in the treatment of chronic pulmonary heart disease with heart failure.Methods:80 patients of chronic pulmonary heart disease with heart failure were randomly divided into Urokinase and Aspirin group (observation group,40 cases) and Aspirin group (control group,40 cases),and received conventional therapy of Metoprolol,Diuretics,Digitalis medicines,observed 2 weeks.Results:The effective rate of observation group was 85%,the co... |
| |
| Keywords: | Chronic pulmonary heart disease Heart failure Urokinase Aspirin |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
